Chemo mouth is a common side effect of undergoing chemotherapy. Dr. Rajiv Saini discusses the symptoms, risks and best ...

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug ...

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug ...

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and ...

A multilevel, navigation-based intervention led to more timely initiation of postoperative radiation therapy vs. usual care-based patient navigation for people with head and neck squamous cell ...

NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and ...

Head and neck cancer is diagnosed in at least 700,000 patients each year. A team of 27 doctors has found a comforting means ...

DUBAI, United Arab Emirates;February 2025 - Throat cancer is one of the fastest-growing cancers, and it is often linked to ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.

CINCINNATI (WKRC) — Mysta Bee, a young artist battling throat cancer, is advancing to the next phase of his treatment plan. Diagnosed after a mass on his neck left him unable to breathe, Mysta Bee, ...